Vaccines invented by the Serum Institute and Bharat Biotech have not been approved for use in India for coronovirus infection on an emergency basis. The country’s drug regulator, the Drug Controller General of India (DCGI), has not yet approved the vaccines of the two companies. Indian media NDTV reported this.
On Wednesday, the Regulatory Subject Expert Committee (SEC) asked for more information on the ‘Ecovishield’ of Seram Institute and Bharat Biotech’s ‘Ecovacion’. The experts will examine the information at the next meeting. DCGI will take a final decision only after receiving their report.
The Pfizer-Bioentech corona ticker has recently been introduced in the UK. Since then, Pfizer has turned a blind eye to the Indian market. The company has sought permission from the government for marketing the vaccine in India.
Within 24 hours of the arrival of this news, the Serum Institute was working to market a potential vaccine made by Oxford-AstraZeneca. She was the first Indian agency to apply to DCGI for permission to apply Ecovishield to Corona patients on an emergency basis. Bharat Biotech made the same request. The company wants an emergency exemption for its potential Corona vaccine, Ecovacion.
The committee of experts met on Wednesday at the request of the two organizations. Although news of the rejection of the first application had spread, the Health Ministry tweeted that the news was fake. The application was not rejected.
Sources said both companies have been asked for more information about the vaccine. That information will be investigated in the next meeting. It is unknown at this time what he will do after leaving the post.
Prime Minister Narendra Modi has held several meetings in India on the distribution of vaccines. He has held meetings with various states and even political parties.